Evaxion A (EVAX) Profit After Tax (2020 - 2026)
Evaxion A (EVAX) reported Profit After Tax of -$3.6 million for Q1 2026, down 129.68% on a YoY basis from $12.2 million in Q1 2025, and up 38.68% quarter-over-quarter from -$5.9 million in Q4 2025.
Evaxion A (EVAX) Profit After Tax (2020 - 2026) Analysis & Trends
Evaxion A has reported Profit After Tax for 7 years, with the latest figure at -$3.6 million in Q1 2026.
- For the quarter ending Q1 2026, Profit After Tax fell 129.68% year-over-year to -$3.6 million; the trailing twelve-month figure through Mar 2026 stood at -$9.8 million (up 26.85% YoY), and the FY2025 full-year result was -$7.7 million, up 27.07% from the prior year.
- Profit After Tax for Q1 2026 stood at -$3.6 million, up from -$5.9 million in the prior quarter.
- The five-year high for Profit After Tax was $4.6 million in Q3 2025, with the low at -$6.9 million in Q4 2022.
- Historically, Profit After Tax has averaged -$4.0 million across 5 years, with a median of -$4.8 million in 2025.
- Annual changes were most pronounced in 2022 — Profit After Tax sank 256.34% — and 2025, when it surged 338.66%.
- Evaxion A's Profit After Tax stood at -$6.9 million in 2022, then soared by 34.18% to -$4.5 million in 2023, then increased by 19.77% to -$3.6 million in 2024, then sank by 63.08% to -$5.9 million in 2025, then soared by 38.68% to -$3.6 million in 2026.
- The last three Profit After Tax figures came in at -$3.6 million (Q1 2026), -$5.9 million (Q4 2025), and $4.6 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | -26.94 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | -2.97 Mn |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | 30.90 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | -14.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -3.63 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | -753,254.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 1.03 Bn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -56.74 Mn |
| 10 | Regeneron Pharmaceuticals | 63.60 Bn | 54.85 Bn | 3.31 Bn | 727.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3.63 Mn |
| Dec 31, 2025 | -5.92 Mn |
| Sep 30, 2025 | 4.62 Mn |
| Jun 30, 2025 | -4.83 Mn |
| Mar 31, 2025 | -1.58 Mn |
| Dec 31, 2024 | -3.63 Mn |
| Sep 30, 2024 | -1.94 Mn |
| Jun 30, 2024 | -6.20 Mn |
| Mar 31, 2024 | 1.19 Mn |
| Dec 31, 2023 | -4.52 Mn |
| Sep 30, 2023 | -5.68 Mn |
| Jun 30, 2023 | -5.68 Mn |
| Mar 31, 2023 | -6.24 Mn |
| Dec 31, 2022 | -6.87 Mn |
| Sep 30, 2022 | -5.74 Mn |
| Jun 30, 2022 | -4.77 Mn |
| Mar 31, 2022 | -6.40 Mn |
| Dec 31, 2021 | -8.37 Mn |
| Sep 30, 2021 | 5.25 Mn |
| Jun 30, 2021 | -6.82 Mn |